Journal article

PET quantification of brain O-GlcNAcase with [18F]LSN3316612 in healthy human volunteers

JH Lee, JS Liow, S Paul, CL Morse, MB Haskali, L Manly, S Shcherbinin, JC Ruble, N Kant, EC Collins, HN Nuthall, P Zanotti-Fregonara, SS Zoghbi, VW Pike, RB Innis

Ejnmmi Research | SPRINGER | Published : 2020

Abstract

Background: Previous studies found that [18F]LSN3316612 was a promising positron emission tomography (PET) radioligand for imaging O-GlcNAcase in nonhuman primates and human volunteers. This study sought to further evaluate the suitability of [18F]LSN3316612 for human clinical research. Methods: Kinetic evaluation of [18F]LSN3316612 was conducted in a combined set of baseline brain scans from 17 healthy human volunteers and test-retest imaging was conducted in 10 of these volunteers; another 6 volunteers had whole-body scans to measure radiation exposure to body organs. Total distribution volume (VT) estimates were compared for the one- and two-tissue compartment models with the arterial inp..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

This work was supported jointly by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (NIMH; project numbers ZIAMH002793 and ZIAMH002852), and a Cooperative Research and Development Agreement (CRADA) with Eli Lilly and Co.